Why is P & G Health Ltd falling/rising?

As of 23-Sep, Procter & Gamble Health Ltd's stock price is currently at 6,287.00, reflecting an increase of 32.55 (0.52%). The stock has outperformed its sector today by 0.87%, although it has seen a decline of 0.80% over the past week and 4.36% over the past month. Despite this recent downturn, the company has demonstrated strong performance over the longer term, with a year-to-date return of 20.21% and a one-year return of 20.10%. Positive factors contributing to the stock's recent movement include high management efficiency, a low debt-to-equity ratio, and consistent positive quarterly results, which have led to high institutional holdings at 21.15%. However, concerns about poor long-term growth and a high valuation relative to its peers may be contributing to some investor caution.
In the broader market context, the stock's recent performance contrasts with the Sensex, which has declined by 0.34% over the past week and increased by 0.98% over the past month. While Procter & Gamble Health Ltd has outperformed the benchmark in the long term, its short-term performance has not mirrored this trend, indicating a potential divergence in investor sentiment. The stock's liquidity remains adequate for trading, but a significant drop in delivery volume suggests a decrease in investor participation, which could be a factor in its recent price movements.